Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Forearm modified Bier block with lidocaine alone or combined with dexmedetomidine or meperidine
IRCT20170823035874N2Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lidocaine, dexmedetomidine and pethidine in None (3 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoint: Sensory block without motor block in dependent traumatized limb. Started Jan 2018; status: completed.
02
Drugs
lidocainedexmedetomidinepethidine
Beyond the preview
Go deeper on IRCT20170823035874N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170823035874N2.